Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
A 59-year-old female with longstanding history of tachyarrhythmias was admitted for syncope and recurrent ventricular tachycardia. She had a past medical history of hyperlipidemia, hypothyroidism, atrial fibrillation, and wide complex tachycardia that had been attributed to Wolf-Parkinson-White syndrome. Her medications included atenolol, propafenone, synthroid, and lipitor. Her 12-lead ECG was notable for sinus rhythm with marked 1st degree heart block, right bundle branch block, and left anterior fascicular block (Figure 1). The echocardiogram on admission demonstrated a moderately dilated left ventricle with normal wall thickness. There was global left ventricular hypokinesis with an estimated ejection fraction (LVEF) of 20%. There was mild right ventricular dilatation with mild global reduction in right ventricular systolic function.Figure 1
- Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455-69. CrossRef
- Tachibana T, Iwai K, Takemura T. Study on the cause of death in patients with sarcoidosis in Japan. In: Presented at XII World Congress on Sarcoidosis, Kyoto, Japan; 1991.
- Hiraga H, Yuwai K, Hiroe M, et al. Guideline for the diagnosis of cardiac sarcoidosis study report on diffuse pulmonary diseases. Tokyo: Japanese Military of Health and Welfare; 1993. p. 23-4.
- Sekiguchi M, Yazaki Y, Isobe M, et al. Cardiac Sarcoidosis: Diagnostic, prognostic and therapeutic considerations. Cardiovasc Drugs Ther 1996;10:495-510. CrossRef
- Patel MR, Cawley PJ, Heitner JF, et al. Delayed enhanced MRI improves the ability to detect involvement in patients with sarcoidosis. Circulation. 2004;110:2995. CrossRef
- Smedema JP, Snoep G, van Kroonenburgh MPG, van Geuns RJ, et al. The additional value of enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128:1629-37. CrossRef
- Vignaux O. Cardiac sarcoidosis: Spectrum of MRI features. AJR 2005;184:249-54.
- Yamagashi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with 13N-NH3/18FDG PET. J Nucl Med 2003;44:1030-6.
- Okumuro W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, et al. Usefulness of fasting PET in the diagnosis of cardiac sarcoidosis. J Nucl Med 2004;45(12):1989-98.
- Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET
Journal of Nuclear Cardiology
Volume 17, Issue 2 , pp 328-332
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Noninvasive Cardiovascular Imaging Program, Departments of Radiology and Medicine (Cardiology), Brigham and Women’s Hospital, 75 Francis Street, ASB1-L1, Boston, MA, 02115, USA
- 2. Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
- 3. Cardiovascular Division (Department of Medicine), Brigham and Women’s Hospital, Boston, MA, USA